Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
about
Antiproteases for acute pancreatitisHow and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysisNSAIDs and Acute Pancreatitis: A Systematic ReviewRethinking information delivery: using a natural language processing application for point-of-care data discoveryEndoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitisPrevention of Post-ERCP Pancreatitis
P2860
Q24235717-A4FAAF47-1537-4996-B688-EC295316FA74Q27008448-CF0EB238-A7AD-4679-AFB3-4C6D9926F62CQ33664210-04BFD589-CF55-4651-AB39-05D00AF27561Q34238306-980AFECD-8309-4F51-9BF5-7AC1260B1A97Q34390035-3CB7F9CF-4AF3-4209-B178-48ED395E8565Q35931242-B4E5925A-A5A0-40EA-9085-57762B7796B0Q58701407-21A77116-03FC-4771-88BA-BAF78560A098
P2860
Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@en
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@nl
type
label
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@en
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@nl
prefLabel
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@en
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@nl
P2093
P1476
Nafamostat mesylate in the pre ...... rs for post-ERCP pancreatitis.
@en
P2093
Cheol Woong Choi
Dae Hwan Kang
Dong Uk Kim
Geun Am Song
Gwang Ha Kim
Il Doo Kim
Jae Sup Eum
Sun Mi Lee
P356
10.1016/J.GIE.2008.10.046
P407
P577
2009-04-01T00:00:00Z